Reply to 'Breaking down peripartum cardiomyopathy: A learning adventure'.

The article discusses the EURObservational Research Programme (EORP) Registry on peripartum cardiomyopathy (PPCM), a disease that affects women during pregnancy or shortly after giving birth. The registry included over 700 patients and provided valuable research opportunities. However, due to the lack of financial incentives, the registry had limitations in terms of follow-up data. The article also mentions the potential for using electrocardiographic and echocardiographic data from the registry for deep learning-based screening, but highlights the need for data from healthy peripartum controls. The lack of a circulating biomarker for PPCM is also discussed, along with the importance of early diagnosis. The article concludes by mentioning ongoing research on heart failure treatments and the potential use of microRNA-146a as a biomarker. [Extracted from the article]